Literature DB >> 16305762

[Generalised joint hypermobility and benign joint hypermobility syndrome. II: epidemiology and clinical criteria].

Lars Remvig1, Dorte Vendelbo Jensen.   

Abstract

Gender-, age- and race-related generalised joint hypermobility (GJH) is elucidated, based on publications that have used validated criteria for GJH. Furthermore, we analysed the connection between GJH and the clinical criteria for benign joint hypermobility syndrome (BJHS), and we looked for literature on the treatment of BJHS. There seems to be evidence in support of an increased prevalence of hypermobility among children, females and certain races when the diagnosis of hypermobility is based on the Carter and Wilkinson criteria (> or =3 positive tests out of 5) and/or Beighton's tests (> or =4 positive tests out of 9). However, there are no unequivocal statements that hypermobility predisposes to the various clinical situations used as major or minor criteria for BJHS, e.g., arthralgia, low back and pelvic pain, joint luxation, soft tissue rheumatism, abnormal cutis or genitourinary prolapse, varicose veins and hernia. There have been no randomised controlled studies of the effect of treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16305762

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  2 in total

1.  Epidemiology of Generalized Ligamentous Laxity in Iran: A National Study Including Different Iranian Ethnic Groups and its Relationship with Musculoskeletal Disorders.

Authors:  Hossein Saremi; Mohammad H Ebrahimzadeh; Sepehr Shiruei; Manoochehr Karami; Alireza Rouhani; Omid Reza Momenzadeh; Mohsen Mardani-Kivi; Hanon Sadoni; Farnaz Shahbazi; Mohammad Dehghani; Ali Karbalaeikhani
Journal:  Arch Bone Jt Surg       Date:  2022-03

2.  Epidemiology of generalized joint laxity (hypermobility) in fourteen-year-old children from the UK: a population-based evaluation.

Authors:  Jacqui Clinch; Kevin Deere; Adrian Sayers; Shea Palmer; Chris Riddoch; Jonathan H Tobias; Emma M Clark
Journal:  Arthritis Rheum       Date:  2011-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.